Qnovia

Healthcare & Life Sciences

Recent Finacing

Recent Raise

Qnovia, Inc. develops proprietary inhalation device technologies, including the RespiRx™ Nicotine Inhaler, for various therapeutic applications.

Total Funding

Headquarters

Founded

Website

Focus Areas

Pharmaceutical

Inhalation Device

Nicotine Inhaler

Clinical Development

Regulatory Development

Therapeutic Indications

Investors